Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP.

MLA

Chapman, M.John, et al. “Duality of Statin Action on Lipoprotein Subpopulations in the Mixed Dyslipidemia of Metabolic Syndrome: Quantity vs Quality over Time and Implication of CETP.” Journal of Clinical Lipidology, vol. 12, no. 3, May 2018, p. 784–800.e4. EBSCOhost, https://doi.org/10.1016/j.jacl.2018.02.001.

APA

Chapman, M. J., Orsoni, A., Robillard, P., Therond, P., & Giral, P. (2018). Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. Journal of Clinical Lipidology, 12(3), 784–800.e4. https://doi.org/10.1016/j.jacl.2018.02.001

Chicago

Chapman, M. John, Alexina Orsoni, Paul Robillard, Patrice Therond, and Philippe Giral. 2018. “Duality of Statin Action on Lipoprotein Subpopulations in the Mixed Dyslipidemia of Metabolic Syndrome: Quantity vs Quality over Time and Implication of CETP.” Journal of Clinical Lipidology 12 (3): 784–800.e4. doi:10.1016/j.jacl.2018.02.001.